Preclinical and clinical safety data includes [5] : No evidence of mutagenic activity, chromosomal aberrations, or micronucleus formation in genotoxicity studies 6-month chronic oral administration studies in rats showed no toxicological concerns 9-month studies in cynomolgus monkeys revealed general safety Six human clinical trials spanning 0.25 mg to 30 mg doses for up to 6 months No serious adverse events or withdrawals related to AOD9604 intake No anti-AOD9604 antibodies detected, indicating low immunogenic potential No changes in vital signs, physical examinations, electrocardiograms, or safety-related laboratory parameters Research Applications A Quick Review AOD9604 is a peptide compound that has shown potential in research related to lipid metabolism, energy balance, and tissue regeneration
This layered strategy addresses hair loss from multiple angles
BioMed research international , 2021 , 9924314
10 Week Supply of Vitamin B12 Injections $99 | Click Photo Intramuscular vs Subcutaneous Injection Vitamin B12 injections can be administered as an intramuscular or subcutaneous injection
Amino Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe Molecular Formula: C78H123N23O23S2 Molecular Weight: 1815.1 g/mol CAS #: 221231-10-3 InChI: 1S/C78H123N23O23S2/c1-9-41 Proper storage ensures AOD 9604 peptide stability for research applications: Lyophilized Form: Reconstituted Form: Handle peptides in clean laboratory environments using sterile techniques
